BURLINGTON, Mass., Aug. 12, 2024 -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the ...
Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. This partnership brings together GENEWIZ's industry-leading ...
Since the first approved gene therapy trial in 1990, interest in cell and gene therapies has increased rapidly, changing the course of research on disease prevention and treatment. However, there are ...
Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences Provides vital insights through sophisticated ...
BURLINGTON, Mass., Oct. 19, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting GENEWIZ Week ...
Azenta, Inc. today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market. The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results